Apellis Pharmaceuticals Competitors and Similar CompaniesClear all
Apellis Pharmaceuticals's competitors and similar companies include Reata Pharmaceuticals.
 Apellis Pharmaceuticals Apellis Pharmaceuticals is a biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic compounds. |  Reata Pharmaceuticals Reata Pharmaceuticals is a biopharmaceutical company that develops therapeutics for patients with serious or life-threatening diseases. | |
Founding Date | Founding Date 2009 | Founding Date 2002 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Waltham, US HQ Kew East, AU München, DE Zug, CH San Francisco, US Watertown, US | Locations Plano, US HQ Irving, US Plano, US |
Employees | Employees 7028% decrease | Employees 3217% decrease |
Valuation ($) | Valuation ($) 3.3 b | Valuation ($) 6.6 b |
Financial | ||
Revenue (est.) | Revenue (est.) $1b (FY, 2025) | Revenue (est.) $2.2m (FY, 2022) |
Net income | Net income $22.4m (FY, 2025) | Net income ($311.9m) (FY, 2022) |
Funding | ||
Total funding raised | Total funding raised $ 88m | Total funding raised $ 468.9m |
For sources of this data, please see the company profile
View Company Profiles
Reata Pharmaceuticals
HQ
Plano, US
Employees
321↓ 7% decrease
Reata Pharmaceuticals is a biopharmaceutical company that develops therapeutics for patients with serious or life-threatening diseases.
View company